Menu ×

HEALTHCARE & PHARMACEUTICAL

Potassium-Sparing Diuretics Market Segmentation by Use (Edema, Hypertension, Heart Failure, Liver Cirrhosis, and Others); and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others) – Global Demand Analysis and Opportunity Outlook 2030

  • Text Size:

Extensive insights into the Growth of Potassium-Sparing Diuretics Market amidst COVID-19

Before we witness the stabilization of economic growth in Europe and North America, Asia Pacific is estimated to bounce back progressively with countries such as China, India, South Korea and Japan witnessing more opportunities to recover from the losses sustained during COVID-19.

Being the biggest market in Eastern Europe, Russia is estimated to take the lowest hit, offering a sigh of relief to the businesses operating in the country. Whereas, GCC is estimated to observe low investments due to the sliding prices of crude oil.

We evaluate the strategies and commitment of the Giant Players in the market towards creating products and services that customers value and rely on.

In an attempt to control and eliminate the surge of coronavirus cases and meet the demand for required medical devices along with providing efficient medical services, there is a drastic shift of investments from authoritative bodies towards the healthcare sector. Where the aftermath of this pandemic may take years to be measured, Research Nester estimates notable expansion of e-health, gaming, and media and entertainment industries till the whole situation is contained and the plan of action for the recovery process is determined. There is an estimated probability of the growth in businesses going back a year if the condition is controlled in the next 2-3 months.                                                         Request Insights

Read More

IN THE NEWS

  • May 2021: Teva Pharmaceutical Industries Ltd. announced its launch of the first available generic version in the U.S. of THIOLA (tiopronin) tablets. This product helps the patients to prevent kidney stones and can be used for both adults & pediatric patients above nine years of age.

  • April 2021: Merck Sharp & Dohme Corp. completed the acquisition of Pandion Therapeutics. After this acquisition, Pandion Therapeutics became a wholly-owned subsidiary of Merck Sharp & Dohme Corp.

Global Potassium-Sparing Diuretics Market Highlights 2022-2030

The global potassium-sparing diuretics market is estimated to grow with a moderate CAGR during the forecast period, i.e., 2022-2030. The increasing prevalence of hypertension and other associated disorders, along with the potassium loss caused due to the use of other diuretics, are expected to fuel the progress of this market. The increase in the elderly population and the change in lifestyle patterns have given way to the prevalence of various metabolic disorders among people on a global scale which has led to an increase in demand for diuretics. Potassium-sparing diuretics are being adopted increasingly for the treatment as they have the capacity to decrease the fluids assimilated inside the body without causing potassium loss and thus, relax the blood vessels. Generally, thiazide and loop diuretics cause the excretion of potassium from the body along with other fluids, which can lead to the deficiency of potassium in the body. Low levels of serum potassium may lead to imbalanced blood pressure, and nerve & muscle function. Potassium-sparing diuretics control the loss of potassium from the body, which is essential in preventing the development of various diseases caused due to potassium deficiency, such as hypertension. This is estimated to boost the market growth. The growth of the market can also be attributed to factors such as the rising consumption of unhealthy food and the technological advancements in diuretics on a global level. According to the data collected from World Health Organization, it was estimated that in 2019, 1.13 billion people globally suffered from hypertension, of which two-thirds of people were living in low and middle-income regions.

potassium-sparing diuretics market Graph

The market is segmented on the basis of use into edema, hypertension, heart failure, liver cirrhosis, and others, out of which, the hypertension segment is anticipated to grab the largest share by the end of 2030 on account of high rate of prevalence of hypertension worldwide. Moreover, the increase in consumption of unhealthy food, which is one of the major risk factors for hypertension, is also projected to contribute to the growth of the segment during the forecast period.

On the basis of distribution channel, the hospital pharmacies’ segment in the global potassium-sparing diuretics market is projected to grow with a significant CAGR over the forecast period. The growth of the segment can be attributed to the fact that a considerable portion of the population with hypertension and associated disorders tend to choose hospital facilities for treatment on a global level, which in turn, support the growth of hospital pharmacies. CLICK TO DOWNLOAD SAMPLE REPORT

Major Macro-Economic Indicators Impacting the Market Growth

Healthcare Expenditure Per Capital Graph

According to the statistics by the World Health Organization, the global per capita healthcare expenditure amounted to USD 1,064.741 in the year 2017. The worldwide healthcare expenditure per person grew from USD 864.313 in 2008 to USD 1,110.841 in 2018, where the U.S. is the top country that amounted to healthcare expenditure of USD 10, 623.85 per capita in 2018. As of 2018, the domestic general government healthcare spending in the U.S. was USD 5355.79, which grew from USD 3515.82 in 2008. These are some of the factors responsible for market growth over the past few years. Moreover, as per the projections by the Centers for Medicare & Medicaid Services (CMS), the estimated average annual percent change related to National Health Expenditures (NHE) in the U.S. was 5.2% in 2020 as compared to 2019 (4.5%). Furthermore, the National Health Expenditures are projected to reach USD 6,192.5 Billion in 2028, where the per capita expenditure is estimated to touch USD 17,611 in the same year. These are notable indicators that are anticipated to create lucrative business opportunities in upcoming years.

Global Potassium-Sparing Diuretics Market Regional Synopsis

Geographically, the market is segmented into North America, Latin America, Europe, Asia Pacific and the Middle East & Africa region. The market in the Asia Pacific is predicted to grow at the highest CAGR over the forecast period owing to the increasing incidence of hypertension-related disorders among the individuals and the increasing product penetration in the region by major market players. Moreover, growing geriatric population in the region is another major factor estimated to boost the market growth.

Furthermore, in 2030, the market in the North America is evaluated to occupy the largest share in terms of revenue, owing to the rise in prevalence of diuresis, edema and other diuretic medical conditions, accompanied by the presence of leading market players in the region. Along with this, North America also leads in terms of clinical research activities, which is also expected to contribute to the market growth in the region.

Potassium-Sparing Diuretics Market Share Image

The global potassium-sparing diuretics market is further classified on the basis of region as follows:

  • North America (U.S. & Canada) Market size, Y-O-Y growth & Opportunity Analysis
  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth & Opportunity Analysis
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC, Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y growth & Opportunity Analysis
  • Asia-Pacific (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y growth & Opportunity Analysis
  • Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y growth & Opportunity Analysis

Market Segmentation

Our in-depth analysis of the global potassium-sparing diuretics market includes the following segments:

By Use

  • Edema
  • Hypertension
  • Heart Failure
  • Liver Cirrhosis
  • Others

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others

Growth Drivers

  • Increasing Prevalence of Hypertension and Associated Disorders
  • Potassium Loss Caused Due to the Use of other Diuretics

Challenges

  • Strict Regulations Governing the Market
  • Abnormally High Potassium Levels Leading to Hyperkaliemia Due to the Use of Potassium-Sparing Diuretics

Key Players Dominating the Market

  • Pfizer Inc.
    • Company Overview
    • Business Strategy
    • Key Product Offerings
    • Financial Performance
    • Key Performance Indicators
    • Risk Analysis
    • Recent Development
    • Regional Presence
    • SWOT Analysis 
  • Merck Sharp & Dohme Corp.
  • Accord Healthcare
  • Amneal Pharmaceuticals LLC
  • Centaur Pharmaceuticals Pvt. Ltd.
  • Validus Pharmaceuticals LLC
  • Teva Pharmaceutical Industries Ltd.
  • CMP Pharma
  • Boehringer Ingelheim GmbH
  • Bayer AG

FREQUENTLY ASKED QUESTIONS


Related Reports


Disclaimer | Privacy Policy | Terms & Conditions

Copyright © 2021 Research Nester. All Rights Reserved